Zantac

With Health Care, the Profit Motive is Infectious

Sam Leff | Posted 09.25.2009 | Politics


Sam Leff

The fact that the medical industrial complex suppressed the cure for stomach ulcers for nearly 15 years raises crucial questions about trusting a system which demonstrably favors corporate profits over patient health.

CVS to Pay $37.5 Million to Settle Pill Switching Case

Wall Street Journal | Jacob Goldstein | Posted 03.28.2008 | Business


CVS is paying $36.7 million to settle allegations that the company defrauded the government by improperly switching patients taking generic Zantac to ...